A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis
NCT03492398
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
HY209
Sponsor
Shaperon